Vol 2026, No 2 (2026)

Table of Contents

Research & Development

Boehringer Ingelheim and Simcere Forge US$1.26 B Collaboration to Advance Inflammatory Bowel Disease Bispecific Antibody Abstract pdf html
Hitesh Udar
Lilly Signs US$1.9 B Global Collaboration with Repertoire for Autoimmune Diseases Abstract pdf html
Hitesh Udar
AstraZeneca Signs US$18.5 B Licensing Pact with CSPC Pharmaceutical Group for Obesity and Type 2 Diabetes Treatments Abstract pdf html
Naini Anand
Lilly Signs US$8.85 B Oncology and Immunology Partnership with Innovent Biologics Abstract pdf html
Hitesh Udar

Licensing

Madrigal Pharmaceuticals Strikes Global Licensing Pact with Suzhou Ribo Life Science to Advance siRNA Metabolic Programmes Abstract pdf html
Nikita Negi & Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.